Lymphangioleiomyomatosis: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
CSV import
 
Line 1: Line 1:
{{SI}}
{{Infobox medical condition
| name            = Lymphangioleiomyomatosis
| image          = [[File:Lymphangioleiomyomatosis.jpg|250px]]
| caption        = Micrograph of lymphangioleiomyomatosis
| field          = [[Pulmonology]]
| synonyms        = LAM
| symptoms        = [[Shortness of breath]], [[chest pain]], [[cough]], [[pneumothorax]], [[chylothorax]]
| complications  = [[Respiratory failure]], [[pulmonary hypertension]], [[kidney]] [[angiomyolipoma]]
| onset          = Typically in women of childbearing age
| duration        = Chronic
| causes          = [[Genetic mutation]] in the [[TSC1]] or [[TSC2]] genes
| risks          = Female gender, [[tuberous sclerosis complex]]
| diagnosis      = [[CT scan]], [[lung biopsy]], [[pulmonary function test]]
| differential    = [[Asthma]], [[chronic obstructive pulmonary disease]], [[interstitial lung disease]]
| treatment      = [[Sirolimus]], [[everolimus]], [[lung transplantation]]
| medication      = [[Bronchodilators]], [[hormonal therapy]]
| prognosis      = Variable, can lead to progressive [[lung disease]]
| frequency      = Rare, estimated 3-5 per million women
| deaths          = Can be fatal if untreated
}}
[[File:Lymphangioleiomyomatosis_-_low_mag.jpg|Lymphangioleiomyomatosis - low magnification|thumb|left]]
[[File:Lymphangioleiomyomatose_CT.jpg|Lymphangioleiomyomatosis CT scan|thumb]]
[[File:Diagnostic_Algorithm_for_Lymphangioleiomyomatosis.jpg|Diagnostic Algorithm for Lymphangioleiomyomatosis|thumb|left]]
'''Lymphangioleiomyomatosis''' ('''LAM''') is a rare lung disease that typically affects women of childbearing age. In LAM, muscle cells that line the lungs' airways and blood vessels begin to multiply abnormally. These LAM cells form clusters and can cause blockages, leading to a variety of symptoms.
'''Lymphangioleiomyomatosis''' ('''LAM''') is a rare lung disease that typically affects women of childbearing age. In LAM, muscle cells that line the lungs' airways and blood vessels begin to multiply abnormally. These LAM cells form clusters and can cause blockages, leading to a variety of symptoms.
== Symptoms ==
== Symptoms ==
The symptoms of LAM can vary greatly from person to person. Some people may have no symptoms at all, while others may experience:
The symptoms of LAM can vary greatly from person to person. Some people may have no symptoms at all, while others may experience:
Line 8: Line 31:
* [[Fatigue]]
* [[Fatigue]]
* [[Wheezing]]
* [[Wheezing]]
== Causes ==
== Causes ==
The exact cause of LAM is unknown. However, it is believed to be related to mutations in the [[TSC1]] or [[TSC2]] genes. These genes are involved in controlling cell growth, and mutations can lead to uncontrolled growth and division of cells.
The exact cause of LAM is unknown. However, it is believed to be related to mutations in the [[TSC1]] or [[TSC2]] genes. These genes are involved in controlling cell growth, and mutations can lead to uncontrolled growth and division of cells.
== Diagnosis ==
== Diagnosis ==
Diagnosis of LAM can be challenging, as its symptoms are similar to those of other lung diseases. However, certain tests can help in the diagnosis:
Diagnosis of LAM can be challenging, as its symptoms are similar to those of other lung diseases. However, certain tests can help in the diagnosis:
Line 18: Line 39:
* [[Biopsy]]
* [[Biopsy]]
* [[Blood test]]
* [[Blood test]]
== Treatment ==
== Treatment ==
There is currently no cure for LAM, but treatments can help manage symptoms and slow the progression of the disease. These may include:
There is currently no cure for LAM, but treatments can help manage symptoms and slow the progression of the disease. These may include:
Line 25: Line 45:
* [[Lung transplantation]]
* [[Lung transplantation]]
* Medications such as [[sirolimus]]
* Medications such as [[sirolimus]]
== Prognosis ==
== Prognosis ==
The prognosis for individuals with LAM varies. Some people may remain stable for many years, while others may experience a rapid progression of the disease.
The prognosis for individuals with LAM varies. Some people may remain stable for many years, while others may experience a rapid progression of the disease.
== See also ==
== See also ==
* [[Tuberous sclerosis]]
* [[Tuberous sclerosis]]
* [[Pulmonary fibrosis]]
* [[Pulmonary fibrosis]]
* [[Pulmonary hypertension]]
* [[Pulmonary hypertension]]
[[Category:Rare diseases]]
[[Category:Rare diseases]]
[[Category:Lung disorders]]
[[Category:Lung disorders]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]
{{stub}}
{{stub}}
<gallery>
File:Lymphangioleiomyomatosis.jpg|Lymphangioleiomyomatosis
File:Lymphangioleiomyomatosis_-_low_mag.jpg|Lymphangioleiomyomatosis - low magnification
File:Lymphangioleiomyomatose_CT.jpg|Lymphangioleiomyomatosis CT scan
File:Diagnostic_Algorithm_for_Lymphangioleiomyomatosis.jpg|Diagnostic Algorithm for Lymphangioleiomyomatosis
</gallery>

Latest revision as of 21:21, 12 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Lymphangioleiomyomatosis
Synonyms LAM
Pronounce N/A
Specialty N/A
Symptoms Shortness of breath, chest pain, cough, pneumothorax, chylothorax
Complications Respiratory failure, pulmonary hypertension, kidney angiomyolipoma
Onset Typically in women of childbearing age
Duration Chronic
Types N/A
Causes Genetic mutation in the TSC1 or TSC2 genes
Risks Female gender, tuberous sclerosis complex
Diagnosis CT scan, lung biopsy, pulmonary function test
Differential diagnosis Asthma, chronic obstructive pulmonary disease, interstitial lung disease
Prevention N/A
Treatment Sirolimus, everolimus, lung transplantation
Medication Bronchodilators, hormonal therapy
Prognosis Variable, can lead to progressive lung disease
Frequency Rare, estimated 3-5 per million women
Deaths Can be fatal if untreated


Lymphangioleiomyomatosis - low magnification
Lymphangioleiomyomatosis CT scan
File:Diagnostic Algorithm for Lymphangioleiomyomatosis.jpg
Diagnostic Algorithm for Lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is a rare lung disease that typically affects women of childbearing age. In LAM, muscle cells that line the lungs' airways and blood vessels begin to multiply abnormally. These LAM cells form clusters and can cause blockages, leading to a variety of symptoms.

Symptoms[edit]

The symptoms of LAM can vary greatly from person to person. Some people may have no symptoms at all, while others may experience:

Causes[edit]

The exact cause of LAM is unknown. However, it is believed to be related to mutations in the TSC1 or TSC2 genes. These genes are involved in controlling cell growth, and mutations can lead to uncontrolled growth and division of cells.

Diagnosis[edit]

Diagnosis of LAM can be challenging, as its symptoms are similar to those of other lung diseases. However, certain tests can help in the diagnosis:

Treatment[edit]

There is currently no cure for LAM, but treatments can help manage symptoms and slow the progression of the disease. These may include:

Prognosis[edit]

The prognosis for individuals with LAM varies. Some people may remain stable for many years, while others may experience a rapid progression of the disease.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia